242 related articles for article (PubMed ID: 12635026)
1. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
Proske S; Uter W; Schnuch A; Hartschuh W
Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
[TBL] [Abstract][Full Text] [Related]
2. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
Schnuch A; Gefeller O; Uter W
Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
[TBL] [Abstract][Full Text] [Related]
3. [A severe epicutaneous test reaction to the bufexamac in a hemorrhoidal therapeutic preparation].
Bauer A; Greif C; Gebhardt M; Elsner P
Dtsch Med Wochenschr; 1999 Oct; 124(40):1168-70. PubMed ID: 10548947
[TBL] [Abstract][Full Text] [Related]
4. Allergic contact dermatitis to topical preparations of bufexamac.
Pan Y; Nixon R
Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467
[TBL] [Abstract][Full Text] [Related]
5. Photo Koebner phenomenon in erythema-multiforme-like eruption induced by contact dermatitis due to bufexamac.
Kurumaji Y
Dermatology; 1998; 197(2):183-6. PubMed ID: 9732173
[TBL] [Abstract][Full Text] [Related]
6. [Contact allergies caused by bufexamac].
Geier J; Fuchs T
Med Klin (Munich); 1989 Jul; 84(7):333-8. PubMed ID: 2529420
[TBL] [Abstract][Full Text] [Related]
7. Vesicular Contact Reaction May Progress into Erythema Multiforme.
Czarnecka-Operacz M; Jenerowicz D; Szulczyńska-Gabor J; Teresiak-Mikołajczak E; Szyfter-Harris J; Bowszyc-Dmochowska M
Acta Dermatovenerol Croat; 2016 Dec; 24(4):307-309. PubMed ID: 28128086
[TBL] [Abstract][Full Text] [Related]
8. [Anogenital dermatoses--allergic and irritative causative factors. Analysis of IVDK data and review of the literature].
Kügler K; Brinkmeier T; Frosch PJ; Uter W
J Dtsch Dermatol Ges; 2005 Dec; 3(12):979-86. PubMed ID: 16405714
[TBL] [Abstract][Full Text] [Related]
9. Allergic contact dermatitis with spreading over extensive regions due to topical use of 5% bufexamac ointment.
Arikawa J; Okabe S; Kaneko T
J Dermatol; 2004 Feb; 31(2):136-8. PubMed ID: 15160871
[No Abstract] [Full Text] [Related]
10. Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: report of 4 cases.
Koch P; Bahmer FA
Contact Dermatitis; 1994 Aug; 31(2):97-101. PubMed ID: 7750277
[TBL] [Abstract][Full Text] [Related]
11. [Severe contact dermatitis caused by Parfenac cream].
Collet E; Lacroix M; Boulitrop Morvan C; Dalac S; Sallin J; Lambert D
Ann Dermatol Venereol; 1993; 120(12):892-3. PubMed ID: 8074349
[TBL] [Abstract][Full Text] [Related]
12. Erythema multiforme-like generalized allergic contact dermatitis caused by Alpinia galanga.
Hong SJ; Chang CH
Contact Dermatitis; 2006 Feb; 54(2):118-20. PubMed ID: 16487286
[TBL] [Abstract][Full Text] [Related]
13. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?
Häusermann P; Harr T; Bircher AJ
Contact Dermatitis; 2004; 51(5-6):297-310. PubMed ID: 15606657
[TBL] [Abstract][Full Text] [Related]
14. [Contact allergy to bufexamac].
Frosch PJ; Raulin C
Hautarzt; 1987 Jun; 38(6):331-4. PubMed ID: 2958428
[TBL] [Abstract][Full Text] [Related]
15. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
[No Abstract] [Full Text] [Related]
16. Allergic contact dermatitis in patients with anogenital complaints.
Bauer A; Geier J; Elsner P
J Reprod Med; 2000 Aug; 45(8):649-54. PubMed ID: 10986683
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer.
Kränke B; Szolar-Platzer C; Komericki P; Derhaschnig J; Aberer W
Contact Dermatitis; 1997 Apr; 36(4):212-5. PubMed ID: 9165205
[TBL] [Abstract][Full Text] [Related]
18. Bufexamac and diclofenac: frequency of contact sensitization and absence of cross-reactions.
Barbaud A; Tréchot P; Aublet-Cuvelier A; Reichert-Penetrat S; Schmutz JL
Contact Dermatitis; 1998 Nov; 39(5):272-3. PubMed ID: 9840280
[No Abstract] [Full Text] [Related]
19. Bufexamac is a frequent contact sensitizer.
Kränke B; Derhaschnig J; Komericki P; Aberer W
Contact Dermatitis; 1996 Jan; 34(1):63-4. PubMed ID: 8789232
[No Abstract] [Full Text] [Related]
20. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children.
Mailhol C; Lauwers-Cances V; Rancé F; Paul C; Giordano-Labadie F
Allergy; 2009 May; 64(5):801-6. PubMed ID: 19183418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
